Analysis for iShares MSCI South Korea ETF
Analysis summary
iShares MSCI South Korea ETF (EWY) currently has a total score of 69 points, placing it in the strong range. The score is made up of Performance (63), Stability (63) and Trend (95). All three sub-scores are currently above average.
Performance scores 63 points (strong). Key strength: 1Y return at 133.3 %. Even the weakest return is still strong in absolute terms: 5Y return at 42.4 %. This points to a sharper upswing more recently.
Stability scores 63 points (strong). Key strength: Sharpe ratio (90d) at 3.08. Main drag: max drawdown (5Y) at -50.8 %. That indicates meaningful multi-year drawdowns. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.
Trend scores 95 points (very strong). Key strength: Price is about 21.1 % above SMA50. Even the weakest metric remains solid in absolute terms: trend strength at 0.88.
Overall, the profile has a clear strength in Trend, while Performance is the main limiter. On a metric level, Sharpe ratio (90d) stands out, while max drawdown (5Y) is the main weak spot.
(Historical evaluation, not investment advice.)
Metrics
Performance
Stability
FAQ
- What investor type does iShares MSCI South Korea ETF fit best in FoxScore?
- iShares MSCI South Korea ETF fits a trend/momentum-oriented investor type in FoxScore: trend is clearly the strongest sub-score. This can be useful if you follow trends — but pay close attention to stability (drawdowns/volatility) because trend signals can flip quickly.
- How meaningful is the available history for iShares MSCI South Korea ETF?
- iShares MSCI South Korea ETF currently has about 15 years of price history available. That covers multiple market cycles including crisis phases, making long-term interpretation of returns, drawdowns and trend shifts more reliable.
- What is FoxScore good for — and what is it not for?
- FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.